Novo Nordisk is a focused healthcare company and the world leader in diabetes care. We know that we cannot create all the answers in-house, so we actively engage in collaborations with academia and simultaneously welcome innovation and talented young scientists through our fellowship programs - our future depends on our ability to work with the best scientists with the competencies we need.
To support this, Novo Nordisk has for more than 20 years driven several dedicated fellowship programs for joint PhD and postdoc projects.
For fellows joining the STAR program, it is a gateway to a life-changing career. With access to state-of-the-art technology we are able to fast track from basic/applied research to new innovative medicines, and by collaborating with our R&D organisation, the STAR fellow will be helping to change the lives of patients.
Currently, the STAR Program supports:
The STAR Program continues to support many young scientists and currently around 35 fellows are enrolled in the program.
Furthermore, Novo Nordisk participates in a number of industry-academia collaborations and consortia supported by EU funding (such as IMI or Horizon2020 MSCA), which also includes a number of postdoc and PhD projects at the company.